BioCryst Pharmaceuticals, Inc.
oral small-molecule therapeutics
- B2B
- B2C
About BioCryst Pharmaceuticals, Inc.
Development of oral small-molecule and protein therapeutics targeting hereditary angioedema and other rare, difficult-to-treat diseases worldwide.
Key facts
- Industry
- Biotechnology Research
- Company size
- 251–1,000 employees
- Headquarters
- Durham, North Carolina, United States
- Founded
- 1986
- Revenue
- $875MFY2025, publicly reported
- Website
- biocryst.com
BioCryst Pharmaceuticals, Inc. at a glance
BioCryst Pharmaceuticals, Inc. is a B2B/B2C company in the Biotechnology Research industry, headquartered in Durham, North Carolina, United States.
BioCryst Pharmaceuticals, Inc. was founded in 1986.
BioCryst Pharmaceuticals, Inc. has 251–1,000 employees.
BioCryst Pharmaceuticals, Inc.'s revenue is $875M (FY2025, publicly reported).
Frequently asked questions about BioCryst Pharmaceuticals, Inc.
What is BioCryst Pharmaceuticals, Inc.'s revenue?
BioCryst Pharmaceuticals, Inc.'s revenue is $875M (FY2025, publicly reported).
How many employees does BioCryst Pharmaceuticals, Inc. have?
BioCryst Pharmaceuticals, Inc. has 251–1,000 employees.
Where is BioCryst Pharmaceuticals, Inc. headquartered?
BioCryst Pharmaceuticals, Inc. is headquartered in Durham, North Carolina, United States.
Selling to companies like BioCryst Pharmaceuticals, Inc.?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies